Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Bravaccini

Showing results (81-90 of 144) with videos related to

Pageof 15
Sort By:
Frontiers in Cell and Developmental Biology|December 17, 2021
The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic EffectsSara Bravaccini, Giuseppe Bronte, Elisabetta Petracci, et al.
Journal of Biotechnology|July 28, 2005
Development and characterization of a monoclonal antibody directed against human telomerase reverse transcriptase (hTERT)Dario Soldateschi, Sara Bravaccini, Brunilde Berti, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 27, 2015
Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapyAndrea Rocca, Daniele Andreis, Anna Fedeli, et al.
Expert Opinion on Pharmacotherapy|March 25, 2017
Sorafenib for the treatment of breast cancerGiuseppe Bronte, Daniele Andreis, Sara Bravaccini, et al.
The EMBO Journal|February 10, 2025
Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancerJamil Nehme, Sjors Maassen, Sara Bravaccini, et al.
Urologic Oncology|November 13, 2012
Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary dataValentina Casadio, Daniele Calistri, Michela Tebaldi, et al.
Scientific Reports|March 11, 2018
PSMA expression: a potential ally for the pathologist in prostate cancer diagnosisSara Bravaccini, Maurizio Puccetti, Martine Bocchini, et al.
Neoplasia (New York, N.Y.)|May 22, 2004
Urine telomerase: an important marker in the diagnosis of bladder cancerMaria Aurora Sanchini, Sara Bravaccini, Laura Medri, et al.
Panminerva Medica|September 21, 2020
CAR T cells targeting options in the fight against multiple myelomaFabio Nicolini, Sara Bravaccini, Massimiliano Mazza, et al.
Oncotarget|February 11, 2017
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancerRoberta Maltoni, Valentina Casadio, Sara Ravaioli, et al.
Pageof 15

Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
Frontiers in Cell and Developmental Biology|December 17, 2021
The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic EffectsSara Bravaccini, Giuseppe Bronte, Elisabetta Petracci, et al.
Journal of Biotechnology|July 28, 2005
Development and characterization of a monoclonal antibody directed against human telomerase reverse transcriptase (hTERT)Dario Soldateschi, Sara Bravaccini, Brunilde Berti, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 27, 2015
Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapyAndrea Rocca, Daniele Andreis, Anna Fedeli, et al.
Expert Opinion on Pharmacotherapy|March 25, 2017
Sorafenib for the treatment of breast cancerGiuseppe Bronte, Daniele Andreis, Sara Bravaccini, et al.
The EMBO Journal|February 10, 2025
Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancerJamil Nehme, Sjors Maassen, Sara Bravaccini, et al.
Urologic Oncology|November 13, 2012
Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary dataValentina Casadio, Daniele Calistri, Michela Tebaldi, et al.
Scientific Reports|March 11, 2018
PSMA expression: a potential ally for the pathologist in prostate cancer diagnosisSara Bravaccini, Maurizio Puccetti, Martine Bocchini, et al.
Neoplasia (New York, N.Y.)|May 22, 2004
Urine telomerase: an important marker in the diagnosis of bladder cancerMaria Aurora Sanchini, Sara Bravaccini, Laura Medri, et al.
Panminerva Medica|September 21, 2020
CAR T cells targeting options in the fight against multiple myelomaFabio Nicolini, Sara Bravaccini, Massimiliano Mazza, et al.
Oncotarget|February 11, 2017
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancerRoberta Maltoni, Valentina Casadio, Sara Ravaioli, et al.
Pageof 15